Ledger.Open graph →

SEC Form D · Amendment · filed December 26, 2019

Entrada Therapeutics, Inc

Offering

$59.0M

Sold

$34.0M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

BOSTON, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Natarajan Sethuraman · Boston, MAExec John Crowley · Cranbury, NJDirector Nathan Dowden · Boston, MAExec Christine Brennan · Boston, MADirector Manager of the General Partner CrossHarbor Capital Partners LLC · Boston, MAExec Louis Tartaglia · Boston, MADirector Kush Parmar · Boston, MADirector Anja Harmeier · Watertown, MADirector Dipal Doshi · Boston, MAExec · Director Todd Foley · CAMBRIDGE, MADirector Mario Saltarelli · Boston, MAExec Christopher Kemp · Seatttle, WAExec John Crowley · Silver Spring, MDDirector Nathan Dowden · Boston, MAExec Louis Tartaglia · San Francisco, CADirector Kush Parmar · San Francisco, CADirector Christine Brennan · Boston, MADirector Anja Harmeier · Watertown, MADirector Dipal Doshi · Boston, MAExec · Director Todd Foley · South San Francisco, CADirector Mario Saltarelli · Boston, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗